Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Update on the pathogenesis of central nervous system lupus.

Nikolopoulos D, Fanouriakis A, Boumpas DT.

Curr Opin Rheumatol. 2019 Aug 13. doi: 10.1097/BOR.0000000000000655. [Epub ahead of print]

PMID:
31415031
2.

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.

Arthritis Rheumatol. 2019 Aug 6. doi: 10.1002/art.40930. [Epub ahead of print]

PMID:
31385462
3.

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.

Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5. Review.

PMID:
31383717
4.

Response to: 'Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations' by Orsolini et al.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jul 30. pii: annrheumdis-2019-215944. doi: 10.1136/annrheumdis-2019-215944. [Epub ahead of print] No abstract available.

PMID:
31362992
5.

Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud et al.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jul 11. pii: annrheumdis-2019-215817. doi: 10.1136/annrheumdis-2019-215817. [Epub ahead of print] No abstract available.

PMID:
31296499
6.

Response to: 'Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus' by Rua-Figueroa and Erausquin.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jul 3. pii: annrheumdis-2019-215810. doi: 10.1136/annrheumdis-2019-215810. [Epub ahead of print] No abstract available.

PMID:
31270111
7.

Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun 14. pii: annrheumdis-2019-215615. doi: 10.1136/annrheumdis-2019-215615. [Epub ahead of print] No abstract available.

PMID:
31201171
8.

An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment.

Frangou E, Vassilopoulos D, Boletis J, Boumpas DT.

Autoimmun Rev. 2019 Aug;18(8):751-760. doi: 10.1016/j.autrev.2019.06.011. Epub 2019 Jun 8. Review.

PMID:
31181324
9.

Chloroquine as alternative antimalarial in systemic lupus erythematosus: response to '2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine' by Figueroa-Parra et al.

Fanouriakis A, Bertsias GK, Boumpas DT.

Ann Rheum Dis. 2019 Jun 8. pii: annrheumdis-2019-215746. doi: 10.1136/annrheumdis-2019-215746. [Epub ahead of print] No abstract available.

PMID:
31177098
10.

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.

Panousis NI, Bertsias GK, Ongen H, Gergianaki I, Tektonidou MG, Trachana M, Romano-Palumbo L, Bielser D, Howald C, Pamfil C, Fanouriakis A, Kosmara D, Repa A, Sidiropoulos P, Dermitzakis ET, Boumpas DT.

Ann Rheum Dis. 2019 Aug;78(8):1079-1089. doi: 10.1136/annrheumdis-2018-214379. Epub 2019 Jun 5.

11.

Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study.

Boumpas DT, Sidiropoulos P, Settas L, Szczypa P, Tsekouras V, Hernandez Daly AC.

Health Qual Life Outcomes. 2019 Apr 29;17(1):73. doi: 10.1186/s12955-019-1127-8.

12.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
13.

Imaging Risk in Multisystem Inflammatory Diseases.

Ikonomidis I, Makavos G, Katsimbri P, Boumpas DT, Parissis J, Iliodromitis E.

JACC Cardiovasc Imaging. 2019 Mar 8. pii: S1936-878X(19)30179-2. doi: 10.1016/j.jcmg.2018.06.033. [Epub ahead of print] Review.

PMID:
30878436
14.

Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus.

Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dörner T, Diamond B, Jacobsen S, Jayne D, Kamen DL, McCune WJ, Mosca M, Ramsey-Goldman R, Ruiz-Irastorza G, Schneider M, Urowitz M, Wofsy D, Smolen JS, Naden RP, Aringer M, Costenbader KH.

Ann Rheum Dis. 2019 May;78(5):634-640. doi: 10.1136/annrheumdis-2018-214685. Epub 2019 Jan 28.

15.

REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A).

Frangou E, Chrysanthopoulou A, Mitsios A, Kambas K, Arelaki S, Angelidou I, Arampatzioglou A, Gakiopoulou H, Bertsias GK, Verginis P, Ritis K, Boumpas DT.

Ann Rheum Dis. 2019 Feb;78(2):238-248. doi: 10.1136/annrheumdis-2018-213181. Epub 2018 Dec 18.

16.

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

Johnson SR, Khanna D, Daikh D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, Hiepe F, Sánchez-Guerrero J, Massarotti E, Boumpas DT, Costenbader KH, Jayne D, Dörner T, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Aringer M.

J Rheumatol. 2019 Jul;46(7):721-726. doi: 10.3899/jrheum.180478. Epub 2018 Dec 15.

PMID:
30554156
17.

Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry.

Gergianaki I, Fanouriakis A, Adamichou C, Spyrou G, Mihalopoulos N, Kazadzis S, Chatzi L, Sidiropoulos P, Boumpas DT, Bertsias G.

Lupus. 2019 Jan;28(1):104-113. doi: 10.1177/0961203318816820. Epub 2018 Dec 6.

PMID:
30522399
18.

Sexual dimorphism in SLE: above and beyond sex hormones.

Christou EAA, Banos A, Kosmara D, Bertsias GK, Boumpas DT.

Lupus. 2019 Jan;28(1):3-10. doi: 10.1177/0961203318815768. Epub 2018 Dec 1. Review.

19.

IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion.

Gkirtzimanaki K, Kabrani E, Nikoleri D, Polyzos A, Blanas A, Sidiropoulos P, Makrigiannakis A, Bertsias G, Boumpas DT, Verginis P.

Cell Rep. 2018 Oct 23;25(4):921-933.e5. doi: 10.1016/j.celrep.2018.09.001.

20.

2008-2018: a decade of recommendations for systemic lupus erythematosus.

Boumpas DT, Bertsias GK, Fanouriakis A.

Ann Rheum Dis. 2018 Nov;77(11):1547-1548. doi: 10.1136/annrheumdis-2018-214014. No abstract available.

PMID:
30309872
21.

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.

Flouri ID, Markatseli TE, Boki KA, Papadopoulos I, Skopouli FN, Voulgari PV, Settas L, Zisopoulos D, Iliopoulos A, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P.

J Rheumatol. 2018 Jun;45(6):785-794. doi: 10.3899/jrheum.170477. Epub 2018 Apr 1.

22.

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi: 10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23.

PMID:
29555348
23.

In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.

Fanouriakis A, Papalopoulos I, Gergianaki I, Spyrou G, Erden A, Rapsomaniki P, Terizaki M, Avgoustidis N, Repa A, Kougkas N, Bertsias G, Boumpas DT, Sidiropoulos PI.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):806-813. Epub 2018 Feb 28.

PMID:
29533750
24.

Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.

Gossec L, Kirwan JR, de Wit M, Balanescu A, Gaujoux-Viala C, Guillemin F, Rat AC, Saraux A, Fautrel B, Kvien TK, Dougados M; RAID investigators.

Clin Rheumatol. 2018 Jun;37(6):1503-1510. doi: 10.1007/s10067-018-3998-1. Epub 2018 Feb 21.

PMID:
29468340
25.

Response to: 'Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus' by Papadaki et al' by Wallace.

Papadaki E, Fanouriakis A, Kavroulakis E, Karageorgou D, Sidiropoulos P, Bertsias G, Simos P, Boumpas DT.

Ann Rheum Dis. 2019 Jan;78(1):e6. doi: 10.1136/annrheumdis-2018-212949. Epub 2018 Jan 23. No abstract available.

PMID:
29363512
26.

Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus.

Papadaki E, Fanouriakis A, Kavroulakis E, Karageorgou D, Sidiropoulos P, Bertsias G, Simos P, Boumpas DT.

Ann Rheum Dis. 2018 Mar;77(3):441-448. doi: 10.1136/annrheumdis-2017-212285. Epub 2017 Dec 19.

PMID:
29259047
27.

Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate.

Moroni G, Gatto M, Raffiotta F, Binda V, Frangou E, Lightstone L, Boumpas DT.

Autoimmun Rev. 2018 Jan;17(1):11-18. doi: 10.1016/j.autrev.2017.11.003. Epub 2017 Nov 3. Review.

28.

Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece.

Gergianaki I, Fanouriakis A, Repa A, Tzanakakis M, Adamichou C, Pompieri A, Spirou G, Bertsias A, Kabouraki E, Tzanakis I, Chatzi L, Sidiropoulos P, Boumpas DT, Bertsias GK.

Ann Rheum Dis. 2017 Dec;76(12):1992-2000. doi: 10.1136/annrheumdis-2017-211206. Epub 2017 Aug 5.

PMID:
28780511
29.

Successful use of sequential B-cell depletion therapy in lupus.

Psarelis S, Nikiphorou E, Boumpas DT.

Lupus. 2018 Feb;27(2):345-346. doi: 10.1177/0961203317717084. Epub 2017 Jun 22. No abstract available.

PMID:
28639929
30.

Evolving Concepts in Systemic Lupus Erythematosus.

Fanouriakis A, Gergianaki I, Sidiropoulos P, Bertsias G, Boumpas DT.

Isr Med Assoc J. 2016 Dec;18(12):749-753. Review. No abstract available.

31.

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):579-585. Epub 2017 Mar 3.

PMID:
28281458
32.

Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.

Kontaki E, Boumpas DT, Tzardi M, Mouzas IA, Papadakis KA, Verginis P.

Autoimmunity. 2017 May;50(3):170-181. doi: 10.1080/08916934.2017.1283405. Epub 2017 Mar 3.

PMID:
28276713
33.

Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.

Zervou MI, Dorschner JM, Ghodke-Puranik Y, Boumpas DT, Niewold TB, Goulielmos GN.

Gene. 2017 Apr 30;610:9-14. doi: 10.1016/j.gene.2017.02.003. Epub 2017 Feb 6.

PMID:
28185859
34.

Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.

Detorakis EE, Magkanas E, Lasithiotaki I, Sidiropoulos P, Boumpas DT, Gourtsoyiannis N, Antoniou K, Raissaki M.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):43-52. Epub 2016 Oct 27.

PMID:
27908307
35.

Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation.

Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, Ritis K, Boumpas DT, Thompson PR, Verginis P, Sidiropoulos P.

Eur J Immunol. 2016 Nov;46(11):2542-2554. doi: 10.1002/eji.201646542. Epub 2016 Oct 5.

36.

Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.

Boubouchairopoulou N, Flouri I, Drosos AA, Boki K, Settas L, Zisopoulos D, Skopouli FN, Papadopoulos I, Iliopoulos A, Kyriopoulos J, Boumpas DT, Athanasakis K, Sidiropoulos P.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):999-1005. Epub 2016 Oct 7.

PMID:
27749220
37.

Differential Expression of miR-4520a Associated With Pyrin Mutations in Familial Mediterranean Fever (FMF).

Latsoudis H, Mashreghi MF, Grün JR, Chang HD, Stuhlmüller B, Repa A, Gergiannaki I, Kabouraki E, Vlachos GS, Häupl T, Radbruch A, Sidiropoulos P, Doukoumetzidis K, Kardassis D, Niewold TB, Boumpas DT, Goulielmos GN.

J Cell Physiol. 2017 Jun;232(6):1326-1336. doi: 10.1002/jcp.25602. Epub 2016 Dec 20.

PMID:
27636101
38.

Is it primary neuropsychiatric systemic lupus erythematosus? Performance of existing attribution models using physician judgment as the gold standard.

Fanouriakis A, Pamfil C, Rednic S, Sidiropoulos P, Bertsias G, Boumpas DT.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):910-917. Epub 2016 Jul 26.

39.

Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population.

Myrthianou E, Zervou MI, Budu-Aggrey A, Eliopoulos E, Kardassis D, Boumpas DT, Kougkas N, Barton A, Sidiropoulos P, Goulielmos GN.

Scand J Rheumatol. 2017 May;46(3):180-186. doi: 10.1080/03009742.2016.1199734. Epub 2016 Jul 20.

PMID:
27440135
40.

Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.

Fanouriakis A, Pamfil C, Sidiropoulos P, Damian L, Flestea A, Gusetu G, Rednic S, Bertsias G, Boumpas DT.

Lupus. 2016 May;25(6):627-36. doi: 10.1177/0961203315622821. Epub 2015 Dec 21.

PMID:
26692040
41.

Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4.

Krasoudaki E, Banos A, Stagakis E, Loupasakis K, Drakos E, Sinatkas V, Zampoulaki A, Papagianni A, Iliopoulos D, Boumpas DT, Bertsias GK.

Nephrol Dial Transplant. 2016 Oct;31(10):1676-86. doi: 10.1093/ndt/gfv374. Epub 2015 Nov 5.

PMID:
26546590
42.

Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation.

Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias GK, Sidiropoulos P, Boumpas DT, Verginis P.

Arthritis Rheumatol. 2016 Feb;68(2):449-61. doi: 10.1002/art.39441.

43.

Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis.

Choulaki C, Papadaki G, Repa A, Kampouraki E, Kambas K, Ritis K, Bertsias G, Boumpas DT, Sidiropoulos P.

Arthritis Res Ther. 2015 Sep 19;17:257. doi: 10.1186/s13075-015-0775-2.

44.

Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever.

Repa A, Bertsias GK, Petraki E, Choulaki C, Vassou D, Kambas K, Boumpas DT, Goulielmos G, Sidiropoulos P.

Hum Immunol. 2015 Jul;76(7):488-95. doi: 10.1016/j.humimm.2015.06.007. Epub 2015 Jun 12.

PMID:
26074413
45.

Lupus nephritis management guidelines compared.

Wilhelmus S, Bajema IM, Bertsias GK, Boumpas DT, Gordon C, Lightstone L, Tesar V, Jayne DR.

Nephrol Dial Transplant. 2016 Jun;31(6):904-13. doi: 10.1093/ndt/gfv102. Epub 2015 Apr 28. Review.

46.

Almost half of octogenarians and nonagenarians admitted acutely to internal medicine ward die during admission or within 6 months after discharge: time to redefine treatment goals?

Perysinaki GS, Theodorakopoulou V, Bertsias A, Peteinaraki E, Tsachakis-Mueck N, Giaka M, Bertsias GK, Boumpas DT, Panagiotakis SH.

J Am Geriatr Soc. 2015 Feb;63(2):380-3. doi: 10.1111/jgs.13273. No abstract available.

PMID:
25688610
47.

EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres.

Pamfil C, Fanouriakis A, Damian L, Rinzis M, Sidiropoulos P, Tsivgoulis G, Rednic S, Bertsias G, Boumpas DT.

Rheumatology (Oxford). 2015 Jul;54(7):1270-8. doi: 10.1093/rheumatology/keu482. Epub 2015 Jan 30.

PMID:
25638807
48.

Women's health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: a report from a south-eastern European Expert Meeting.

Ntali S, Damjanov N, Drakakis P, Ionescu R, Kalinova D, Rashkov R, Malamitsi-Puchner A, Mantzaris G, Michala L, Pamfil C, Rednic S, Tektonidou MG, Tsiodras S, Vassilopoulos D, Vojinovic J, Bertsias GK, Boumpas DT.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):959-68. Epub 2014 Nov 7. Review.

PMID:
25436516
49.

Neutrophil extracellular traps regulate IL-1β-mediated inflammation in familial Mediterranean fever.

Apostolidou E, Skendros P, Kambas K, Mitroulis I, Konstantinidis T, Chrysanthopoulou A, Nakos K, Tsironidou V, Koffa M, Boumpas DT, Ritis K.

Ann Rheum Dis. 2016 Jan;75(1):269-77. doi: 10.1136/annrheumdis-2014-205958. Epub 2014 Sep 26.

PMID:
25261578
50.

Neutrophil extracellular traps promote differentiation and function of fibroblasts.

Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis T, Sivridis E, Koffa M, Giatromanolaki A, Boumpas DT, Ritis K, Kambas K.

J Pathol. 2014 Jul;233(3):294-307. doi: 10.1002/path.4359. Epub 2014 May 19.

PMID:
24740698

Supplemental Content

Loading ...
Support Center